Fig. 4From: Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD)Rate ratios for subgroup analyses. a Patients with one previous exacerbation. b Patients with an eosinophil level > 0.3 × 109/L. c Patients with FEV1 < 50% predicted. HCP, healthcare practitioner; GP, General Practitioner; RR, respiratory-related; RRR, routine respiratory-related; SABA, short-acting β2 agonist; SAMA, short-acting muscarinic agonist; URR, unplanned respiratory-relatedBack to article page